Breaking News
Investing Pro 0
🚨 NDVA surged 43%. This AI Chipmaker Could Be Next See Analysis
Close

Abbott Laboratories (0Q15)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
103.3300 -8.0600    -7.24%
14:36:05 - Closed. Currency in USD ( Disclaimer )
  • Volume: 490
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 103.3300 - 103.3300
Type:  Equity
Market:  United Kingdom
ISIN:  US0028241000 
SEDOL:  BYMPY19
Abbott Labs 103.3300 -8.0600 -7.24%

NYSE:0Q15 Financials

 
See below for an overview of the Abbott financial reports. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track the NYSE:ABT financials over time.

Abbott Laboratories reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 9,747 million compared to USD 11,895 million a year ago. Net income was USD 1,318 million compared to USD 2,447 million a year ago. Diluted earnings per share from continuing operations was USD 0.75 compared to USD 1.37 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

0Q15 Income Statement

Gross margin TTM 55.64%
Operating margin TTM 18%
Net Profit margin TTM 13.98%
Return on Investment TTM 12.01%
 Total Revenue  Net Income
Period Ending: Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Total Revenue 9747 10091 10410 11257
Gross Profit 5422 5561 5781 6324
Operating Income 1646 1459 1872 2482
Net Income 1318 1033 1435 2018

0Q15 Balance Sheet

Quick Ratio MRQ 1.07
Current Ratio MRQ 1.68
LT Debt to Equity MRQ 39.83%
Total Debt to Equity MRQ 46%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Total Assets 73794 74438 72801 74202
Total Liabilities 36562 37533 36917 37486
Total Equity 37232 36905 35884 36716

0Q15 Cash Flow Statement

Cash Flow/Share TTM 4.98
Revenue/Share TTM 23.88
Operating Cash Flow  7.87%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 1143 2326 2780 2410
Cash From Investing Activities -462 -632 -484 -264
Cash From Financing Activities -1410 -1457 -1543 -813
Net Change in Cash -721 288 657 1262
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
mac macas
mac macas Jan 10, 2023 4:38
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any up going forecast at 25 January
Bhanwerlal Lava
Bhanwerlal Lava Jan 10, 2023 4:38
Saved. See Saved Items.
This comment has already been saved in your Saved Items
abt lab up slide target 25 jan 25000rs
Bhanwerlal Lava
Bhanwerlal Lava Dec 16, 2022 17:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dowen side target
Bhanwerlal Lava
Bhanwerlal Lava Dec 16, 2022 17:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
up. slide target 30000 rs
Babar Ali
Babar Ali Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
trump sign 750 million deal with Abbott will go up??
Alexander Nygaard
Alexander Nygaard Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
750M deal and the company is valued at 196B... use your brain
Mihai Barbulescu
Mihai Barbulescu Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yeah! It will go up a lot! Like 2%!
Bhanwerlal Lava
Bhanwerlal Lava Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bad results
Bhanwerlal Lava
Bhanwerlal Lava Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bad results go up 3%down
Bhanwerlal Lava
Bhanwerlal Lava Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good result agin 100%up
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email